Actor Song Sun-mi argued with her daughter over wearing a beach outfit.On the 3rd, Song Sun-mi's YouTube channel posted ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

New York City health department officials are concerned after recently released data showed a slight uptick in HIV cases – which comes as the federal government proposes cutting funding to HIV ...

Masonia Traylor folded into a ball in the corner of the patient room. "No," the 23-year-old screamed, over and over again. She was HIV-positive. It came as a surprise to the now 38-year-old from ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 ...

Decades after its discovery, HIV continues to take lives and challenge global health systems. There are many challenges to combating HIV, including the complexity of developing a vaccine for a virus ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...